Some general aspects of the interaction of foreign materials with blood are summarized. The role of protein adsorption in this interaction is briefly discussed. In an attempt to produce more stable antithrombogenic surface coatings than the well-known heparin-bonded surfaces, a method is described in which a high-molecular-weight polyelectrolyte is bound to polymer surfaces. In vitro experiments carried out with freshly drawn human blood show a reduced platelet adhesion on such surfaces.
INTRODUCTION
Two important aspects of the interaction of foreign materials with blood are platelet adhesion and blood coagulation. These processes are dependent on surface properties of the material, on flow conditions, and on the way in which the initial blood-material contact is brought about [l, 21. When a material is exposed to blood, the first event which takes place is the adsorption of proteins from the blood onto the material surface. Upon adsorption of these proteins, the surface of the material will be altered and the subsequent events will be determined by the modified surface.
A schematic representation of the phenomena which occur when a foreign material is contacted with blood is shown in Figure 1 . It must be emphasized that the intrinsic coagulation process can be initiated either on the surface of aggregating platelets [3] or by activation of factor XI1 on the foreign material. During the coagulation process thrombin is formed. Thrombin, being a release inducer, also causes platelet aggregation. Thus in later stages of platelet adhesion /aggregation and intrinsic coagulation there will be a mutual interaction between these processes. Therefore a candidate thromboresistant material must reduce both platelet adhesion and the contact activation of factor XII. adhesion of platelets in these cases can be explained by assuming that the adsorbed glycoproteins fibrinogen and y-globulin interact with platelets. In the model of Lee and Kim [ 10, 111, a glycosyl transferase enzyme located in the platelet membrane forms a complex with a glycoprotein containing incomplete heterosaccharides (e.g., fibrinogen) when adsorbed on a foreign surface. On the other hand, reduced platelet adhesion has been reported for polymers, which adsorb relatively large amounts of albumin, such as some block copolyether urethanes [ 121.
Little is known about the relation between adsorbed proteins and the surface activation of intrinsic coagulation. Preliminary in vitro experiments carried out in our laboratory indicate that this activation is dependent on the type of preadsorbed protein and the surface properties of the material (Feijen et al. [13] ). These results are listed in Tables I and 11 . As can be seen from Table I , albumin-coated surfaces (glass, cuprophane, polystyrene) showed longer plasma coagulation times than surfaces which were coated with fibrinogen or y-globulin. This indicates that polymers which show a preferential adsorption of albumin do not only cause a reduced platelet ad- hesion but also delay the contact activation of intrinsic coagulation. In order to synthesize new polymers which preferentially adsorb albumin from the blood and which may be antithrombogenic, it is important to get more insight into the processes which determine protein adsorption.
THROMBORESISTANT COATINGS
An important method to obtain more thromboresistant polymers is the modification of polymer surfaces by coating them with specific compounds which reduce platelet adhesion and/or blood coagulation. Well-known examples are heparin-bonded surfaces [ 141. Reduced platelet adhesion on such surfaces, mentioned in the literature [15, 161, may be explained by a reduced fibrinogen adsorption, which has also been reported [15, 171. Moreover, antithrombin 111 (AT-111) is adsorbed from plasma by these surfaces and the resulting AT-111-coated surface is capable of binding thrombin and other activated coagulation factors [ 18, 191. Ma However, part of the antithrombogenic properties of heparin-bonded surfaces can be explained by the fact that heparin leakage can occur [14] . Therefore it is difficult to distinguish between the contribution of dissolved heparin and of surface-bound heparin to the nonthrombogenicity of heparinized surfaces. In an attempt to produce more stable thromboresistant surfaces we have coated (hydrophobic) polymers with a synthetic polyelectrolyte (P) containing sulfamate and carboxylate groups:
In recent publications from our group the synthesis [20, 211 and anticoagulant properties [22, 231 of P have been described. It resembles heparin in many aspects. It is an antithrombin and its action is also stimulated by, or is dependent on, a cofactor (presumably AT-111) present in the blood plasma. Like heparin, P can be linked ionically to a polymer surface by means of the adsorptive coupling agent tridodecylmethylammonium chloride (TDMAC). As P has an approximate molecular weight of 750,000, the number of ionic surface bonding sites per molecule is much larger than in ! PVC, u n c o a t e d
1 PVC/P-TDMAC heparin (MW 6,000-20,OOO). Therefore it was expected that the stability of ionic-type surface coatings with P should be superior to the complexes of heparin and TDMAC, and that elution of P from the coatings should be negligible. This was confirmed by desorption experiments carried out by Froehling [24] . He found that in the presence of 0.15M NaCl or bovine plasma no '251-labeled P was eluted from PVC treated with TDMAC.
PVC films, coated with the TDMAC complex of P, showed little or no platelet adhesion when exposed to freshly drawn human blood. Quantitative data concerning the adhesion of blood platelets to glass, polystyrene, PVC and P-coated PVC are listed in Table 111 . These data were obtained from experiments in which the blood was slowly pumped through two parallel flow cells previously filled with saline (thus avoiding blood-air interfaces). One cell contained a reference material, while the other one contained the test material. The cells are nearly identical with the test cell used by Mason et al. [8, 9, 251. An exploded view of one of our cells is shown in Figure 2 . Platelet adhesion and fibrin deposition on the test materials were studied with the aid of a scanning electron microscope (SEM). Activation of intrinsic coagulation was measured by means of a modified PTT test. Experimental details are published elsewhere [26] . SEM photographs of the various materials which had been exposed to blood are shown in Figures 3-6 .
Due to the chemical similarity of P and heparin it is likely that P-coated PVC and heparin-bonded surfaces act in a similar way toward platelets, e.g., via a reduced fibrinogen adsorption. Although we may assume that the complex of P and TDMAC consists of completely neutralized polyelectrolyte, it is possible that the complex is partly dissociated in blood under the influence of plasma salts. In this way, parts of the P molecules remain bound to the sur- face, while other parts of these molecules extend into the liquid. This results in a surface layer of quasidissolved polyelectrolyte. Thus the negatively charged polyelectrolyte may account for the reduced platelet adhesion.
Froehling [24] also found that P-coated PVC delays the contact activation of bovine plasma and he showed that AT-I11 is adsorbed and activated on the surface coating. On the other hand, we measured an enhanced coagulation of human plasma in coated PVC and silicon rubber tubes compared to the uncoated tubes. This may explain the fact that the P'IT value for blood, which had been passed through the flow cell, is not relatively high in the case of P-coated PVC (Table 111) . However, the PTT values from Table I11 may have been influenced by a considerable activation of factor XII, due to the syringe and parts of the cell, especially its narrow inlet and outlet. A further systematic study of the thromboresistant properties of P-coated surfaces, including in vivo experiments, will be carried out in the near future.
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